Craig R. Stapleton, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 20,000 shares at $9.52 ($190K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Open-market purchase of $190k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| FLML | BUY | 2016-11-30 | $216K | — | Filing → |
| ANF | BUY | 2016-09-06 | $177K | — | Filing → |
| FLML | BUY | 2016-09-06 | $135K | — | Filing → |